Pfizer Chips Away At State Claims In Lipitor Antitrust MDL
A New Jersey federal judge has found that state antitrust claims against Pfizer Inc. and Ranbaxy Inc. tied to sales of the blockbuster cholesterol medication Lipitor aren't preempted by federal patent...To view the full article, register now.
Already a subscriber? Click here to view full article